Leucadia Therapeutics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Seed
- Investors
-
4
Leucadia Therapeutics General Information
Description
Developer of a medical technology platform designed to offer novel and advanced treatments for Alzheimer's disease. The company's platform restores CSF flow across the cribriform plate, improving the clearance of toxic metabolites from the earliest regions of the brain to be affected by Alzheimer's disease, enabling healthcare professionals to effectively treat Alzheimer's patients.
Contact Information
Website
www.leucadiatx.comCorporate Office
- 2040 Eastridge Avenue
- Suite B1
- Riverside, CA 92507
- United States
Corporate Office
- 2040 Eastridge Avenue
- Suite B1
- Riverside, CA 92507
- United States
Leucadia Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 25-Jun-2019 | Completed | Generating Revenue | |||
| 1. Seed Round | 17-Dec-2015 | Completed | Startup |
Leucadia Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Leucadia Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Leucadia Therapeutics Patents
Leucadia Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190125288-A1 | Diagnosis and prognosis of medical conditions using cribriform plate morphology | Inactive | 30-Oct-2017 | ||
| WO-2019089642-A1 | Diagnosis and prognosis of medical conditions using cribriform plate morphology | Inactive | 30-Oct-2017 |
Leucadia Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Leucadia Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bioverge | Venture Capital | Minority | ||
| Methuselah Foundation | Not-For-Profit Venture Capital | Minority | ||
| Methuselah Fund | Venture Capital | Minority | ||
| Wasabi Ventures | Venture Capital | Minority |
Leucadia Therapeutics FAQs
-
When was Leucadia Therapeutics founded?
Leucadia Therapeutics was founded in 2015.
-
Where is Leucadia Therapeutics headquartered?
Leucadia Therapeutics is headquartered in Riverside, CA.
-
What is the size of Leucadia Therapeutics?
Leucadia Therapeutics has 3 total employees.
-
What industry is Leucadia Therapeutics in?
Leucadia Therapeutics’s primary industry is Therapeutic Devices.
-
Is Leucadia Therapeutics a private or public company?
Leucadia Therapeutics is a Private company.
-
What is Leucadia Therapeutics’s current revenue?
The current revenue for Leucadia Therapeutics is .
-
How much funding has Leucadia Therapeutics raised over time?
Leucadia Therapeutics has raised $1.5M.
-
Who are Leucadia Therapeutics’s investors?
Bioverge, Methuselah Foundation, Methuselah Fund, and Wasabi Ventures have invested in Leucadia Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
